Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;36(5):881-5.
doi: 10.1007/s10545-012-9547-1. Epub 2012 Oct 30.

Lyso-globotriaosylsphingosine (lyso-Gb3) levels in neonates and adults with the Fabry disease later-onset GLA IVS4+919G>A mutation

Yin-Hsiu Chien  1 , Olaf A Bodamer, Shu-Chuan Chiang, Hermann Mascher, Christina Hung, Wuh-Liang Hwu
Affiliations

Lyso-globotriaosylsphingosine (lyso-Gb3) levels in neonates and adults with the Fabry disease later-onset GLA IVS4+919G>A mutation

Yin-Hsiu Chien et al. J Inherit Metab Dis. 2013 Sep.

Abstract

Lyso-globotriaosylsphingosine (lyso-Gb3) is a useful biomarker in the diagnosis and monitoring of treatment for Fabry disease. However, it is unclear whether lyso-Gb3 is elevated in patients with later-onset Fabry disease. Thus, we measured lyso-Gb3 levels from dried blood spots (DBS) from male newborns with the Fabry disease later-onset phenotype, IVS4+919G>A mutation, and their family members. The lyso-Gb3 levels were below the detection limit in normal control newborns and were slightly higher in adults. In males of all ages with the IVS4+919G>A mutation, lyso-Gb3 levels were elevated and were higher than in age-matched controls. The elevation of lyso-Gb3 levels in males with the IVS4+919G>A mutation was only slightly elevated compared with patients with the classical Fabry phenotype. The measurement of lyso-Gb3 levels is useful in the diagnosis of Fabry disease, including the later-onset phenotype. The DBS lyso-Gb3 level was not elevated in IVS4+919G>A heterozygotes, and is not useful for their diagnosis. Since lyso-Gb3 levels are elevated from birth in Fabry disease males, "an elevated lyso-Gb3 level" may be of little values for deciding when to begin enzyme replacement therapy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2812-7 - PubMed
    1. Biochim Biophys Acta. 2010 Sep;1802(9):741-8 - PubMed
    1. N Engl J Med. 2001 Jul 5;345(1):9-16 - PubMed
    1. Ann Intern Med. 2007 Jan 16;146(2):77-86 - PubMed
    1. Circ Cardiovasc Genet. 2009 Oct;2(5):450-6 - PubMed

Publication types

MeSH terms

LinkOut - more resources

  NODES
INTERN 1
Project 1
twitter 2